Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...
Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trialMAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions ...
Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates multiple neurobiomarker data ...
Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.
Cognision today unveiled Cognision360(TM), a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, standardized system--addressing one of the ...
CANTON, GA, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- Pathwelle, Georgia’s only designated Spinal Flow ...
Research BackgroundCNS infections caused by carbapenem-resistant Enterobacteriaceae (CRE) pose a critical global healthcare challenge. These ...
Today, as a barely above-zero day, is a bit better than tomorrow through Wednesday. Next week’s best days are Thursday and ...
In the next two months, it’s crucial that you separate yourself from the bad choices of others so that you don’t become ...
Following the conclusion of the 2025 Digital European Sky Call for the next phase of the SESAR programme, the SESAR 3 Joint ...
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results